1. Home
  2. LNTH vs KNX Comparison

LNTH vs KNX Comparison

Compare LNTH & KNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • KNX
  • Stock Information
  • Founded
  • LNTH 1956
  • KNX 1989
  • Country
  • LNTH United States
  • KNX United States
  • Employees
  • LNTH N/A
  • KNX N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • KNX Trucking Freight/Courier Services
  • Sector
  • LNTH Health Care
  • KNX Industrials
  • Exchange
  • LNTH Nasdaq
  • KNX Nasdaq
  • Market Cap
  • LNTH 7.5B
  • KNX 7.2B
  • IPO Year
  • LNTH 2015
  • KNX 1994
  • Fundamental
  • Price
  • LNTH $80.19
  • KNX $46.92
  • Analyst Decision
  • LNTH Strong Buy
  • KNX Buy
  • Analyst Count
  • LNTH 5
  • KNX 16
  • Target Price
  • LNTH $133.80
  • KNX $51.47
  • AVG Volume (30 Days)
  • LNTH 1.2M
  • KNX 3.1M
  • Earning Date
  • LNTH 05-07-2025
  • KNX 04-23-2025
  • Dividend Yield
  • LNTH N/A
  • KNX 1.54%
  • EPS Growth
  • LNTH N/A
  • KNX 37.21
  • EPS
  • LNTH 3.53
  • KNX 0.93
  • Revenue
  • LNTH $1,536,699,000.00
  • KNX $7,411,973,000.00
  • Revenue This Year
  • LNTH $5.81
  • KNX $4.64
  • Revenue Next Year
  • LNTH $12.26
  • KNX $7.93
  • P/E Ratio
  • LNTH $22.52
  • KNX $50.11
  • Revenue Growth
  • LNTH 12.53
  • KNX 1.16
  • 52 Week Low
  • LNTH $74.34
  • KNX $36.69
  • 52 Week High
  • LNTH $126.89
  • KNX $61.51
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 29.71
  • KNX 66.30
  • Support Level
  • LNTH $78.61
  • KNX $40.04
  • Resistance Level
  • LNTH $83.60
  • KNX $49.39
  • Average True Range (ATR)
  • LNTH 3.81
  • KNX 1.41
  • MACD
  • LNTH -3.05
  • KNX 1.02
  • Stochastic Oscillator
  • LNTH 5.51
  • KNX 76.78

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About KNX Knight-Swift Transportation Holdings Inc.

Knight-Swift is the largest full-truckload carrier in the US, with a diversified transportation offering. Pro forma for the U.S. Xpress deal, about 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 69% and less than truckload 13%. Truck brokerage and other asset-light logistics services make up 9% of revenue, with intermodal near 6%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue reflects services offered to shippers and third-party truckers, including equipment maintenance and leasing.

Share on Social Networks: